Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

At 4.9% CAGR, Radiopharmaceuticals Market to hit USD 8832.7 Mn to 2028, says Brandessence Market Research

This image opens in the lightbox

News provided by

Brandessence Market Research And Consulting Private Limited

08 Feb, 2022, 13:10 GMT

Share this article

Share toX

Share this article

Share toX

LONDON, Feb. 8, 2022 /PRNewswire/ -- According to Brandessence Market Research, The Radiopharmaceuticals Market size reached 6319.2 Million in 2021. The Radiopharmaceuticals Market is growing at robust CAGR of 4.9%, and reach size of USD 8832.7 Million by end of Forecast 2028.

An increase in the prevalence of cancer and increased use of medical imaging as a diagnostics procedure is the key factor that helps the market to grow. Radiopharmaceutical Market Size, Share, Companies & Trends Analysis Report By Type (Diagnostic Radiopharmaceuticals, Therapeutic Radiopharmaceuticals), By End User (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers), By Application (Cardiology, Neurology, Oncology), Based On Region And Segment Forecasts, 2022 – 2028

Get Sample of Report@ https://brandessenceresearch.com/requestSample/PostId/415

Scope of The Radiopharmaceuticals Market Report:

Radiopharmaceuticals are pharmaceutical agents which contain radioactive materials used for therapeutic or diagnostic procedures. These radioactive materials are mostly radioisotopes that emit gamma radiation of a short wavelength which can destroy the cells. These radiopharmaceuticals are mostly used for cancer cell destruction, arthritis, and treatment for pain. Radiopharmaceuticals are used in various diagnostic procedures, nuclear medicine mostly in medical imaging. One of the major divisions of radiopharmaceuticals is contributed by radiotracers which are used in medical imaging to diagnose any dysfunction in tissues. Around 5-8 years is the typical duration which these radiopharmaceuticals take for the launch in the market and human use.

Radiopharmaceuticals Companies Focusing In this Report:

  • Cardinal Health, Inc.,
  • Advanced Accelerator Applications S.A.,
  • IBA Molecular Imaging,
  • Lantheus Medical Imaging, Inc.,
  • Jubilant Pharma,
  • Mallinckrodt plc,
  • Eczacibasi-Monrol Nuclear Products,
  • GE Healthcare,
  • Bracco Imaging S.p.A,
  • Nordion, Inc.,
  • Bayer Healthcare,
  • Siemens Healthcare
  • Others

Global Radiopharmaceutical Market Segmentation:

By Type

  • Diagnostic Radiopharmaceuticals
  • Therapeutic radiopharmaceuticals

By End-User

  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Centers
  • Others

By Application

  • Cardiology
  • Neurology
  • Oncology
  • Other

There has been tremendous growth in the prevalence of various chronic disorders such as cancer, cardiovascular disorders, and others has fueled the growth of the radiopharmaceutical market. As per the Research UK report, there were around 17 million new cases of cancer has been reported in 2018. As the prevalence of chronic disorders has increased it has also increased the demand for better and accurate diagnosis for better treatment. This in turn has increased the use of medical imaging on a large scale which involves the use of radiopharmaceuticals as a tracer to detect the dysfunctional tissue in the body.

Get Methodology @ https://brandessenceresearch.com/requestMethodology/PostId/415

Reginal Analysis:

North America is expected to dominate the market

North America is expected to account for the major market share and is expected to dominate the market over the forecast period. Due to the presence of developed countries such as U.S., Canada and others coupled with increased prevalence of cancer and medical imaging and increased public awareness. Europe is expected to closely follow North America in terms of market share due to the presence of advanced infrastructure, increase in research & development and technological advancement are expected to promote the growth of the radiopharmaceutical market over the forecast period.

The Asia Pacific is expected to develop significantly in terms of growth rate and maintain its dominance over the forecast period. Increased adoption of advanced technology, increased prevalence of chronic disorders, increase in public awareness, increase in disposable income and others factors are expected to promote the growth of the radiopharmaceutical market. Latin America, Africa and Middle East is expected to develop moderately in the near future.

On Special Requirement Radiopharmaceutical Market Report is also available for below region:

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Sweden
  • Netherland
  • Turkey
  • Switzerland
  • Belgium
  • Rest of Europe

Asia-Pacific

  • South Korea
  • Japan
  • China
  • India
  • Australia
  • Philippines
  • Singapore
  • Malaysia
  • Thailand
  • Indonesia
  • Rest Of APAC

Latin America

  • Mexico
  • Colombia
  • Brazil
  • Argentina
  • Peru
  • Rest of South America

˙Middle East and Africa

  • Saudi Arabia
  • UAE
  • Egypt
  • South Africa
  • Rest Of MEA

Get Full Access of all Report: https://brandessenceresearch.com/technology-and-media/d-scanner-market https://brandessenceresearch.com/healthcare/radiopharmaceutical-market-global-industry

Related Reports :

  • Sterile Filtration Market Size, Trends And Forecast To 2028
  • Pharmaceutical Excipients Global Market Report 2021: COVID-19 Growth and Change to 2028
  • Medical Imaging Reagents Market Size, Share & Trends Analysis Report By Class (Contrast Reagents, Optical Reagents, Nuclear Reagents), By Technology (Nanoparticles, Fluorescent Dyes & Probes, Radiopharmaceuticals, Fluorescent Proteins, Quantum Dots) Based On Region, And Segment Forecasts, 2021 – 2027
  • Graphite Electrode Market Size to hit USD 14.71 Bn to 2028
  • Global Assisted Reproductive Technology Market Size to hit USD 56.18 Billion to 2028
  • Energy Management System Market to Reach USD 223.26 Billion to 2028
  • 3D Scanner Market Size is Expected to Reach USD 1618.5 Million by 2028
  • Blockchain Technology In Healthcare Market to hit USD 513.1 Million to 2028
  • Surgical Instrument Tracking Systems Market to hit USD 513.1 Million to 2028
  • Omega-3 Market to hit USD 4215.7 Million, Globally by 2028
  • Conformal Coatings Market is Expected to Reach 1257.6 Mn by 2028
  • Solar Panels Market size Expected to Reach USD 902.55 Bn, Globally by 2028

i-Factor: Live Market intelligence platform

I-Factor is our guaranteed seal to keep our clients ahead of the competition, always. This knowledge platform delivers real-time updates on key economic indicators, competitive landscape, changing demand, trends, customized regional insights, and more. The platform visualizes key data points to help make decision making agile, trustworthy, and holistic.  Register for free trail here @ https://brandessenceresearch.com/i-factor/login/userRegister

Brandessence Market Research & Consulting Pvt ltd.

Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.

Website: https://brandessenceresearch.com 

Blog: https://brandessenceresearch.com/blog/top-5-automotive-aftermarket-companies-in-global-market-2021 Automotive Aftermarket Top Companies

Follow Us: Linkedin  

Mr. Vishal Sawant 
Email:
 vishal@brandessenceresearch.com 
Email: Sales@brandessenceresearch.com 
Corporate Sales: +44-2038074155
Asia Office: +917447409162

Logo: https://mma.prnewswire.com/media/1392316/BEMR_Logo.jpg

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.